Healthy lifestyle factors and risk of cardiovascular events and mortality in treatment-resistant hypertension: The Reasons for Geographic and Racial Differences in Stroke study

Hypertension

Volumn 64, Issue 3, 2014, Pages 465-471

  Diaz, Keith M ^a   Booth III, John N ^b   Calhoun, David A ^c   Irvin, Marguerite R ^b   Howard, George ^b   Safford, Monika M ^c   Muntner, Paul ^b   Shimbo, Daichi ^a  

^a Department of Medicine   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

Diet; Hypertension; Lifestyle; Smoking

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; POTASSIUM; SODIUM;

AGED; ALBUMINURIA; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; DIABETES MELLITUS; DIETARY APPROACHES TO STOP HYPERTENSION DIET; DISEASE ASSOCIATION; ESTIMATED GLOMERULUS FILTRATION RATE; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; GLOMERULUS FILTRATION RATE; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; POTASSIUM INTAKE; PRIORITY JOURNAL; RACE DIFFERENCE; RESISTANT HYPERTENSION; SODIUM INTAKE; TREATMENT RESISTANT HYPERTENSION; WAIST CIRCUMFERENCE;

DIET; HYPERTENSION; LIFESTYLE; SMOKING;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CONTINENTAL POPULATION GROUPS; DEMOGRAPHY; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; LIFE STYLE; MALE; MOTOR ACTIVITY; PHENOTYPE; PROGNOSIS; RISK FACTORS; SMOKING CESSATION; STROKE; SURVIVAL RATE;

EID: 84907597061     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.03565     Document Type: Article

References (25)

1. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM; American Heart Association Professional Education Committee. Resistant hypertension: Diagnosis, evaluation, and treatment: A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117:e510-e526.
2. Egan BM, Zhao Y, Axon RN, Brzezinski WA, Ferdinand KC. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation. 2011;124:1046-1058.
3. Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL, O'Connor PJ, Selby JV, Ho PM. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation. 2012;125:1635-1642.
4. Irvin MR, Booth JN, Shimbo D, Lackland DT, Oparil S, Howard G, Safford MM, Muntner P, Calhoun DA. Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease and all-cause mortality [published online ahead of print March 17, 2014]. J Am Soc Hypertens. doi:10.1016/j.jash.2014.03. 003. http://www.ashjournal.com/article/S1933-1711(14)00100-4. Accessed March 18, 2014.
5. Bangalore S, Fayyad R, Laskey R, Demicco DA, Deedwania P, Kostis JB, Messerli FH; Treating to New Targets Steering Committee and Investigators. Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease. Am J Med. 2014;127:71-81.e1.
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. J Am Med Assoc. 2003;289:2560-2572.
7. Mancia G, Fagard R, Narkiewicz K, et al; Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281-1357.
8. Howard VJ, Cushman M, Pulley L, Gomez CR, Go RC, Prineas RJ, Graham A, Moy CS, Howard G. The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology. 2005;25:135-143.
9. Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: A systematic review and meta-analysis. BMJ. 2011;342:d671.
10. World Health Organization (WHO). Waist Circumference and Waist- Hip Ratio: Report of a WHO Expert Consultation. Geneva, Switzerland: World Health Organization; 2011.
11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii). J Am Med Assoc. 2001;285:2486-2497.
12. Fung TT, Chiuve SE, McCullough ML, Rexrode KM, Logroscino G, Hu FB. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med. 2008;168:713-720.
13. White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med. 2011;30:377-399.
14. Fagard RH. Resistant hypertension. Heart. 2012;98:254-261.
15. Parikh A, Lipsitz SR, Natarajan S. Association between a DASH-like diet and mortality in adults with hypertension: findings from a populationbased follow-up study. Am J Hypertens. 2009;22:409-416.
16. Rossi A, Dikareva A, Bacon SL, Daskalopoulou SS. The impact of physical activity on mortality in patients with high blood pressure: A systematic review. J Hypertens. 2012;30:1277-1288.
17. Chiuve SE, McCullough ML, Sacks FM, Rimm EB. Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications. Circulation. 2006;114:160-167.
18. Forman JP, Stampfer MJ, Curhan GC. Diet and lifestyle risk factors associated with incident hypertension in women. J Am Med Assoc. 2009;302:401-411.
19. King DE, Mainous AG III, Carnemolla M, Everett CJ. Adherence to healthy lifestyle habits in US adults, 1988-2006. Am J Med. 2009;122:528-534.
20. Dimeo F, Pagonas N, Seibert F, Arndt R, Zidek W, Westhoff TH. Aerobic exercise reduces blood pressure in resistant hypertension. Hypertension. 2012;60:653-658.
21. Warburton DE, Nicol CW, Bredin SS. Health benefits of physical activity: The evidence. CMAJ. 2006;174:801-809.
22. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: A systematic review. J Am Med Assoc. 2003;290:86-97.
23. Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell'Italia LJ, Calhoun DA. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension. 2009;54:475-481.
24. Agarwal R. Resistant hypertension and the neglected antihypertensive: sodium restriction. Nephrol Dial Transplant. 2012;27:4041-4045.
25. Appel LJ. Another major role for dietary sodium reduction: improving blood pressure control in patients with resistant hypertension. Hypertension. 2009;54:444-446. Stroke